Raimar Löbenberg
Raimar Löbenberg
Verified email at ualberta.ca - Homepage
Title
Cited by
Cited by
Year
Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs
E Galia, E Nicolaides, D Hörter, R Löbenberg, C Reppas, JB Dressman
Pharmaceutical research 15 (5), 698-705, 1998
9641998
Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards
R Löbenberg, GL Amidon
European journal of pharmaceutics and biopharmaceutics 50 (1), 3-12, 2000
9012000
Simulated biological fluids with possible application in dissolution testing
MRC Marques, R Loebenberg, M Almukainzi
Dissolution Technol 18 (3), 15-28, 2011
6742011
Targeted delivery of nanoparticles for the treatment of lung diseases
S Azarmi, WH Roa, R Löbenberg
Advanced drug delivery reviews 60 (8), 863-875, 2008
4232008
Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung
JOH Sham, Y Zhang, WH Finlay, WH Roa, R Löbenberg
International Journal of Pharmaceutics 269 (2), 457-467, 2004
3252004
Current perspectives in dissolution testing of conventional and novel dosage forms
S Azarmi, W Roa, R Löbenberg
International Journal of pharmaceutics 328 (1), 12-21, 2007
3222007
Interaction of poly (butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro
RN Alyaudtin, A Reichel, R Löbenberg, P Ramge, J Kreuter, DJ Begley
Journal of drug targeting 9 (3), 209-221, 2001
2152001
Optimization of a two-step desolvation method for preparing gelatin nanoparticles and cell uptake studies in 143B osteosarcoma cancer cells
D Abrams, Y Huang, S McQuarrie, W Roa, H Chen, R Löbenberg, ...
1762006
Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles
S Azarmi, X Tao, H Chen, Z Wang, WH Finlay, R Löbenberg, WH Roa
International journal of pharmaceutics 319 (1-2), 155-161, 2006
1692006
Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit® E100
H Valizadeh, A Nokhodchi, N Qarakhani, P Zakeri‐Milani, S Azarmi, ...
Drug development and industrial pharmacy 30 (3), 303-317, 2004
1612004
Biorelevant dissolution media as a predictive tool for glyburide a class II drug
H Wei, R Löbenberg
European journal of pharmaceutical sciences 29 (1), 45-52, 2006
1592006
Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model
WH Roa, S Azarmi, MHDK Al-Hallak, WH Finlay, AM Magliocco, ...
Journal of controlled release 150 (1), 49-55, 2011
1552011
Dissolution testing as a prognostic tool for oral drug absorption: dissolution behavior of glibenclamide
R Löbenberg, J Krämer, VP Shah, GL Amidon, JB Dressman
Pharmaceutical research 17 (4), 439-444, 2000
1442000
Influence of the surfactant concentration on the body distribution of nanoparticles
L Araujo, R Löbenberg, J Kreuter
Journal of drug targeting 6 (5), 373-385, 1999
1431999
Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after iv injection to rats
R Löbenberg, L Araujo, H von Briesen, E Rodgers, J Kreuter
Journal of controlled release 50 (1-3), 21-30, 1998
1371998
Overview of the preparation of organic polymeric nanoparticles for drug delivery based on gelatine, chitosan, poly (d, l-lactide-co-glycolic acid) and polyalkylcyanoacrylate
P Lai, W Daear, R Löbenberg, EJ Prenner
Colloids and Surfaces B: Biointerfaces 118, 154-163, 2014
1312014
Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery
LG Sweeney, Z Wang, R Loebenberg, JP Wong, CF Lange, WH Finlay
International journal of pharmaceutics 305 (1-2), 180-185, 2005
1192005
Liposomal drug delivery: a versatile platform for challenging clinical applications
A Madni, M Sarfraz, M Rehman, M Ahmad, N Akhtar, S Ahmad, N Tahir, ...
Journal of Pharmacy & Pharmaceutical Sciences 17 (3), 401-426, 2014
1182014
Dynamic dissolution testing to establish in vitro/in vivo correlations for montelukast sodium, a poorly soluble drug
A Okumu, M DiMaso, R Löbenberg
Pharmaceutical research 25 (12), 2778-2785, 2008
1102008
Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration
S Miyazaki, A Takahashi, W Kubo, J Bachynsky, R Löbenberg
J Pharm Pharm Sci 6 (2), 238-245, 2003
1102003
The system can't perform the operation now. Try again later.
Articles 1–20